Pérez-Mercado Jesús Antonio, Gallegos-Durazo Diana Lizeth, Hernández-Donnadieu Jorge Rafael, Copado-Villagrana Edgar Daniel
Instituto Mexicano del Seguro Social, Hospital General de Zona No. 5, Coordinación Clínica de Educación e Investigación. Nogales, Sonora, México.
Instituto Mexicano del Seguro Social, Hospital General de Zona con Medicina Familiar No. 23, Unidad de Vigilancia Epidemiológica Hospitalaria. Parral, Chihuahua, México.
Rev Med Inst Mex Seguro Soc. 2024 Jul 1;62(4):1-4. doi: 10.5281/zenodo.11397093.
Hepatitis C Virus (HCV) infection represents a global public health problem, but in Mexico, the Ministry of Health through the National Epidemiological Surveillance System (SINAVE) only reports the distribution of incident cases by state, sex and epidemiological week.
To determine the seroprevalence and factors associated with HCV in beneficiaries of a Family Medicine Unit of the Mexican Social Security Institute (IMSS) in the city of Nogales, Sonora, located on the border between Mexico and the United States.
Cross-sectional study that included 145 beneficiaries with rapid HCV antibody test results. Information on risk factors was obtained through direct questioning. To compare groups of reactive and non-reactive patients, Fisher's Exact Test was used and a Logistic Regression model to determine Odds Ratio (OR) values. A P value <0.05 was considered statistically significant.
A seroprevalence of 2.8% (95%CI: 0.8 - 6.9) was determined and through the logistic regression model it was found that the history of transfusions (OR: 151.2, 95%CI: 5.9 - 3.858.0) and the use of intranasal drugs (OR: 20.81, 95%CI: 1.3 - 331.3) increase the risk of infection.
The seroprevalence of HCV in Nogales is higher than that of the rest of Mexico. Recent studies establish a history of transfusion as a risk factor, but few have explored intranasal drug use.
丙型肝炎病毒(HCV)感染是一个全球性的公共卫生问题,但在墨西哥,卫生部通过国家流行病学监测系统(SINAVE)仅报告按州、性别和流行病学周划分的新发病例分布情况。
确定位于墨西哥和美国边境的索诺拉州诺加利斯市墨西哥社会保障局(IMSS)家庭医学科受益人群中HCV的血清流行率及相关因素。
采用横断面研究,纳入145名HCV抗体快速检测结果的受益人。通过直接询问获取危险因素信息。为比较反应性和非反应性患者组,使用Fisher精确检验,并采用逻辑回归模型确定比值比(OR)值。P值<0.05被认为具有统计学意义。
确定血清流行率为2.8%(95%CI:0.8 - 6.9),通过逻辑回归模型发现输血史(OR:151.2,95%CI:5.9 - 3858.0)和使用鼻内药物(OR:20.81,95%CI:1.3 - 331.3)会增加感染风险。
诺加利斯市HCV的血清流行率高于墨西哥其他地区。近期研究将输血史确定为危险因素,但很少有研究探讨鼻内药物的使用情况。